JPM vs MUJ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MUJ exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it lacks an Altman Z-Score due to its structure as a closed-end fund. The current price of $12.12 sits comfortably between the Graham Number ($11.43) and the Intrinsic Value ($13.57), suggesting fair valuation. However, the fund faces a critical sustainability issue with a dividend payout ratio of 140.87%, indicating it is returning more capital than it earns. While recent 1-year price performance is positive, stagnant revenue growth and a bearish technical trend offset the stability of its book value.
Compare Another Pair
Related Comparisons
JPM vs MUJ: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and BlackRock MuniHoldings New Jersey Quality Fund, Inc. (MUJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.